Literature DB >> 16918496

Leptin, estrogens and cancer.

María del Carmen Maeso Fortuny1, Buenaventura Brito Díaz, Antonio Cabrera de León.   

Abstract

Obesity is a state of leptin resistance in which the membrane leptin receptor and the JAK-STAT pathway are blocked. This leads to increased intracellular concentrations of lipid metabolites, increased non-oxidative metabolism by adipocytes, and stimulation of the cell estrogen cycle. These factors are potentially oncogenic via the shared mitogen-activated protein kinase (MAPK), mitogen/extracellular signal-regulated kinase (MEK) and extracellular signal-regulated kinase (ERK) cellular pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16918496     DOI: 10.2174/138955706777934973

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  3 in total

Review 1.  Minireview: Obesity and breast cancer: the estrogen connection.

Authors:  Margot P Cleary; Michael E Grossmann
Journal:  Endocrinology       Date:  2009-04-16       Impact factor: 4.736

2.  Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer.

Authors:  Naima Badid; Fatima Zohra Baba Ahmed; Hafida Merzouk; Slimane Belbraouet; Nassima Mokhtari; Sid Ahmed Merzouk; Riad Benhabib; Djalloul Hamzaoui; Michel Narce
Journal:  Pathol Oncol Res       Date:  2010-06       Impact factor: 3.201

3.  Withania somnifera as a potential candidate to ameliorate high fat diet-induced anxiety and neuroinflammation.

Authors:  Taranjeet Kaur; Gurcharan Kaur
Journal:  J Neuroinflammation       Date:  2017-10-12       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.